February 21st 2025
Comorbid conditions accrued at a rate 30% faster among adults with depression than in those without the disorder over a 7-year follow-up period.
Studies Find No Link Between SSRIs and Congenital Heart Disease
June 27th 2007BOSTON -- Use of selective serotonin-reuptake inhibitors (SSRIs) during the first trimester of pregnancy did not significantly increase the risk of congenital heart defects overall, despite FDA and drug maker warnings to the contrary.
Low T3 Level: An Indication for Treatment?
June 1st 2007I am an adult psychiatric nurse practitioner, and a significant part of my practice has been the treatment of subclinical hypothyroidism. Whenever a patient has depression and low energy, I measure free T4, free T3, and thyroid-stimulating hormone (TSH) levels. In most of the subclinical hypothyroidism I have detected, the TSH level is normal. In many cases, the only level that is low is the free T3. When liothyronine is prescribed for these patients, their symptoms of depression and tiredness decrease and their need for antidepressants has, in a few cases, been eliminated.
APA: Successor to Effexor Effective Against Anxiety in Depression
May 23rd 2007SAN DIEGO -- The novel serotonin-norepinephrine reuptake inhibitor desvenlafaxine succinate (Pristiq) was significantly superior to placebo in the treatment of anxiety symptoms in depression, results of a pooled analysis showed.